Novartis Ag (NVSEF) Gross Margin Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Gross Margin Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 972.00
Jun 30, 2024 426.00
Dec 31, 2023 -31,150.00
Jun 30, 2023 526.00
Mar 31, 2023 154.32 Mn
Dec 31, 2022 719,882.00
Sep 30, 2022 -43,239.00
Jun 30, 2022 575.00
Mar 31, 2022 -34,519.00
Dec 31, 2021 -38.00
Sep 30, 2021 -35,007.00
Jun 30, 2021 -38,232.00
Mar 31, 2021 498.19 Mn
Dec 31, 2020 709,876.00
Sep 30, 2020 -139,666.00
Jun 30, 2020 1,541.00
Mar 31, 2020 7,406.00
Jun 30, 2019 -33,937.00
Mar 31, 2019 -73,203.00
Jun 30, 2018 -16,853.00